Clinical Trials Logo

Fatigue clinical trials

View clinical trials related to Fatigue.

Filter by:

NCT ID: NCT01216137 Completed - Multiple Sclerosis Clinical Trials

Effects of Vestibular Rehabilitation on MS-related Fatigue: a Randomized Control Trial

Start date: January 2007
Phase: N/A
Study type: Interventional

The purpose of this study was to test the feasibility and effectiveness of a novel exercise intervention for individuals who live with multiple sclerosis (MS).

NCT ID: NCT01215448 Completed - Fatigue Clinical Trials

Wheatgrass Juice / Lifestyle Recommendations / Cancer Patients' Quality of Life / Chemotherapy Treatment

4001
Start date: October 2010
Phase: N/A
Study type: Interventional

This study is aimed to study the impact of wheatgrass juice and lifestyle recommendations (diet, physical activity and breathing exercises) on the well being, fatigue and hematological parameters of chemotherapy-naive patients with no evidence for symptoms of active oncological disease.The researchers hypothesize that both wheatgrass juice and lifestyle recommendations can improve patient's well-being during chemotherapy.

NCT ID: NCT01205464 Completed - Fatigue Clinical Trials

Effects of Doxycycline on Persistent Symptoms Post-neuroborreliosis

Start date: February 2005
Phase: N/A
Study type: Interventional

The aim of this randomised, double-blind crossover study was to determine whether Doxycycline has an impact on the persistent symptoms post-neuroborreliosis, through alterations in the immune response and whether such an effect could influence the clinical outcome.

NCT ID: NCT01203657 Completed - Physical Activity Clinical Trials

UCLA Tai Chi in a Community Setting Study

Start date: January 2010
Phase: N/A
Study type: Interventional

Although a number of studies have examined the effects of Tai Chi in older adult populations, few have methodically assessed its effects on vitality, fatigue and physical activity. Some studies have shown that fatigue relates to negative mood and poor health-related quality of life in older persons. Tai Chi is an ancient Chinese form of calisthenics that utilizes the body's internal energy (chi), mind, and breathing; which may be a useful exercise for older adults in increasing their activity level. A twenty-four of Yang style of Tai Chi is a simple form of Tai Chi that is particularly well-suited for older adults. This proposed study to investigate the effects of a Tai Chi intervention on decreasing fatigue level, and increasing level of activity in healthy older adults. The investigators research group has focused on the Tai Chi as a strategy to reduce stress and improve sleep, and their preliminary evidence suggest it strongly affects energy level and vitality. The investigators are focused on taking this intervention into the community testing its efficacy. The investigators preliminary data shows that Tai Chi is of benefit to older adults; however, this study will test whether their research findings are generalizable to community settings. Tai Chi-naïve participants from Culver City Senior Center will receive a 10-week Tai Chi. The investigators will compare this group to a wait-list control group. All subjects will receive a packet of questionnaires of pre- and post-intervention vitality, fatigue and health-related quality of life. Subjects will also be given an activity monitor to wear for 2 days before they start the Tai Chi class and for 2 days after they complete the class, to determine if there is a change in general physical activity level.

NCT ID: NCT01198977 Completed - Multiple Sclerosis Clinical Trials

Telehealth-Based Exercise Program to Treat Fatigue in MS

MS-FIT
Start date: October 2009
Phase: N/A
Study type: Interventional

This is a clinical trial examining a brief motivational intervention to improve adherence to exercise among individuals with MS to improve fatigue.

NCT ID: NCT01197144 Completed - Pain Clinical Trials

Pain Modulation in Rheumatoid Arthritis (RA) - Influence of Adalimumab

PARADE
Start date: October 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to obtain increased knowledge concerning central pain and fatigue processing in rheumatoid arthritis, and how these conditions are influenced by treatment with Tumor Necrosis Factor (TNF) blockade with adalimumab.

NCT ID: NCT01169233 Completed - Fatigue Clinical Trials

Operational Evaluation of a Photic Countermeasure to Improve Alertness, Performance, and Mood During Nightshift Work on a 105-day Simulated Human Exploration Mission to Mars

Mars 105
Start date: August 2008
Phase: N/A
Study type: Interventional

The success of human expedition missions critically depend on the ability of the crew to be alert and maintain high levels of cognitive function while operating complex, technical equipment. Optimal human health, performance and safety during space flight requires sufficient sleep and synchrony between the circadian pacemaker—which regulates the timing of sleep, endocrine function, alertness and performance—and the timing of the imposed sleep-wake schedule. Crewmembers of the 105-day simulation study will be required to work one night shift every sixth night. This schedule will likely result in sleep loss and circadian misalignment, especially when lighting conditions are similar to those that crewmembers experience during spaceflight. External mission controllers will work 24-hour shifts, also resulting in both sleep loss and circadian misalignment. It has been well documented in laboratory and field studies that both working the night shift and working extended duration shifts result in decrement alertness, performance and mood. In addition to the negative effects that night shift work has on alertness, performance and mood, shift work causes significant short and long-term health problems. Shift workers, particularly night shift workers who invert their normal sleep/wake schedule, suffer for several reasons. First, their endogenous circadian rhythms and the imposed sleep/work schedule are typically out of phase. This is similar to the experience of jet lag. However, while environment cues (e.g., sunrise, sunset, the timing of meals and sleep) enable travelers to adapt quickly to a new time zone, crewmembers in the 105-day simulation will be unable to do so because they will only spend one night of every five working. When working the night shift, the timing of meals, work, and sleep will therefore be out of phase with the normal entrained phase of the circadian timing system. Ingestion of meals at an inappropriate circadian phase results in impaired metabolism, likely underlying the gastrointestinal and metabolic problems experienced by shift workers. Second, this circadian misalignment leads to a substantial loss of sleep efficiency during the (daytime) sleep period, independent of, and in addition to, environmental obstacles to sleep (e.g., noise, light, other crewmembers). Third, misalignment of circadian phase coupled with sleep loss will each result in deterioration of alertness and impairment of performance during the night. Since these adverse effects are particularly acute on the first night of work, the plan for crewmembers on the Mars 105 mission to work the midnight shift every sixth night will subject them repeatedly to the performance impairments associated with acute circadian misalignment and acute sleep deprivation. Lighting Countermeasure. Our group at the Harvard Medical School has successfully developed and tested effective photic countermeasures to alleviate circadian misalignment and improve alertness, performance and mood in night shift workers. The most effective countermeasure to circadian alignment is appropriately-timed and sufficiently intense light. Light also acutely improves alertness, performance and mood. Most recently it has been reported that short wavelength light has been shown to be most effective for both resetting circadian rhythms and acutely improving performance during night work via antecedent suppression of the soporific hormone melatonin. These photic countermeasures have been tested in individual subjects living in laboratory simulations (Countermeasures readiness level/Technology readiness level 7; Evaluation with human subjects in controlled laboratory simulating operational spaceflight environment). The next critical step is to evaluate our countermeasures in an operational simulation of space flight that includes study of the interaction among crew members in a high fidelity simulation (Countermeasures readiness level/Technology readiness level 8; Validation with human subjects in actual operational spaceflight to demonstrate efficacy and operational feasibility). Adequate sleep and circadian alignment are critical to maintaining the health and performance of expedition mission crewmembers. Testing of the developed lighting countermeasure in a high fidelity operational environment imitating the conditions of a future expedition mission (e.g., to Mars) is critical to ensure countermeasure readiness and to reduce the risk of human performance errors due to factors related to circadian disruption, sleep loss and fatigue. Development and testing of this photic countermeasure for mission controllers working 24-hour shifts will further ensure the success of the future long duration expedition missions.

NCT ID: NCT01164956 Terminated - Cancer Clinical Trials

Methylphenidate for Cancer-Related Fatigue

Start date: July 2011
Phase: Phase 1
Study type: Interventional

The overall aim of this pilot study is to conduct a combined N-of-1 trial (N-1-T) of MPH (methylphenidate) for amelioration of fatigue in children with cancer, and to evaluate the N-1-T design both for individual clinical decision making and for clinical trials in symptom management in pediatric oncology patients. Because no one knows which of the study options are best, participants will receive liquid MPH on some days and a placebo on other days. We will compare how the participant feels on MPH days with how they feel on placebo days to determine whether MPH makes a difference.

NCT ID: NCT01160380 Completed - Multiple Myeloma Clinical Trials

A Study of the Effectiveness of Armodafinil to Treat Cancer-Related Fatigue in Patients With Multiple Myeloma

Start date: June 2010
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy of armodafinil for the treatment of cancer-related fatigue in adult patients with multiple myeloma. The study consists of a screening period, followed by a 56-day treatment phase, and a final assessment to occur 28 days after the end of the last treatment.

NCT ID: NCT01158443 Completed - Hiv Clinical Trials

Behavioral Activation/Armodafinil to Treat Fatigue in HIV/AIDS

Start date: July 2010
Phase: Phase 4
Study type: Interventional

This is an integrated medication/behavioral intervention program to increase energy, activity level and goal attainment in a sample of HIV+ adults whose presenting problems include both clinically significant fatigue and unmet vocational goals. Based on previous studies, the investigators found that many patients fail to achieve desired goals even though energy is restored by medication. To address this failure of goal attainment, the investigators will evaluate a behavioral intervention, originally based on Behavioral Activation Treatment for Depression, and modified as Behavioral Activation Program for Energy and Productivity or BA-PEP. The intervention will be conducted with patients who experience clinically significant fatigue and who want to work or receive work-related training (paid or volunteer, part time or full time) or education once energy improves with medication (armodafinil).